Department of Rehabilitation Medicine, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Department of Neurology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Clin Rehabil. 2024 Jun;38(6):749-769. doi: 10.1177/02692155241235336. Epub 2024 Mar 1.
To evaluate the efficacy and safety of transcranial direct current stimulation in poststroke patients with upper extremity motor dysfunction using a systematic review and meta-analysis.
We searched the Web of Science, Cochrane Library, EMBASE, and PubMed for randomized controlled trials investigating the effects of both active and sham stimulation up until January 27, 2024.
Efficacy, including the upper extremity Fugl-Meyer Assessment, Action Research Arm Test, Barthel Index, and safety, were assessed. The risk of bias was assessed using the Cochrane Risk of Bias 2 tool and the Physiotherapy Evidence Database Scale. Meta-analysis was performed using the RevMan 5.4 software.
Forty-four studies with 1555 participants were included. Transcranial direct current stimulation proved effective in improving upper extremity motor function (standardized mean difference = 0.22, 95% confidence interval: 0.12-0.32, < 0.001) and Barthel Index (mean difference = 4.65, 95% confidence interval: 2.82-6.49, < 0.001). Subgroup analysis revealed the highest transcranial direct current stimulation efficacy in patients with subacute stroke. Both anodal and cathodal stimulation were effective against upper extremity motor dysfunction. C3/C4 was the most effective stimulus target. Optimal stimulation parameters included stimulus current densities <0.057 mA/cm for 20-30 min and <30 sessions. Adverse effects and dropouts during follow-up showed that transcranial direct current stimulation is safe and feasible.
Our findings suggest that both anodal and cathodal stimulation were significantly effective in subacute stroke patients, particularly when preceding other treatments and when C3/C4 is targeted.
通过系统评价和荟萃分析评估经颅直流电刺激对上肢运动功能障碍的脑卒中患者的疗效和安全性。
我们在 Web of Science、Cochrane 图书馆、EMBASE 和 PubMed 上搜索了截至 2024 年 1 月 27 日的评估主动和假刺激影响的随机对照试验。
评估了疗效,包括上肢 Fugl-Meyer 评估、动作研究上肢测试、Barthel 指数,以及安全性。使用 Cochrane 偏倚风险 2 工具和物理治疗证据数据库量表评估了偏倚风险。使用 RevMan 5.4 软件进行荟萃分析。
共纳入 44 项研究,共 1555 名参与者。经颅直流电刺激在改善上肢运动功能(标准化均数差=0.22,95%置信区间:0.12-0.32, < 0.001)和 Barthel 指数(均数差=4.65,95%置信区间:2.82-6.49, < 0.001)方面均有效。亚组分析显示,经颅直流电刺激对亚急性脑卒中患者的疗效最高。阳极和阴极刺激对上肢运动功能障碍均有效。C3/C4 是最有效的刺激靶点。最佳刺激参数包括刺激电流密度<0.057 mA/cm,持续 20-30 分钟,疗程<30 次。随访期间的不良事件和脱落表明经颅直流电刺激是安全可行的。
我们的研究结果表明,阳极和阴极刺激在亚急性脑卒中患者中均显著有效,尤其是在其他治疗之前进行,且以 C3/C4 为靶点时更有效。